Yuko Watanabe

1.7k total citations
68 papers, 1.4k citations indexed

About

Yuko Watanabe is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Yuko Watanabe has authored 68 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 12 papers in Endocrinology, Diabetes and Metabolism and 9 papers in Surgery. Recurrent topics in Yuko Watanabe's work include Hormonal Regulation and Hypertension (9 papers), Ion Transport and Channel Regulation (7 papers) and Parathyroid Disorders and Treatments (7 papers). Yuko Watanabe is often cited by papers focused on Hormonal Regulation and Hypertension (9 papers), Ion Transport and Channel Regulation (7 papers) and Parathyroid Disorders and Treatments (7 papers). Yuko Watanabe collaborates with scholars based in Japan, United States and Canada. Yuko Watanabe's co-authors include Eiji Kusano, Kiyoshi Kawakami, Itaru Okamoto, Yoko Miyake, Akira Ono, Shigeaki Muto, Tetsu Akimoto, Haruki Okamura, Kyosuke Yamanishi and Hisato Matsunaga and has published in prestigious journals such as Angewandte Chemie International Edition, The Journal of Experimental Medicine and Blood.

In The Last Decade

Yuko Watanabe

64 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuko Watanabe Japan 21 644 267 184 150 133 68 1.4k
Guilai Liu Germany 17 900 1.4× 182 0.7× 120 0.7× 76 0.5× 125 0.9× 30 1.6k
Tomohiko Okuda Japan 26 1.1k 1.8× 119 0.4× 162 0.9× 78 0.5× 227 1.7× 49 1.8k
Ewa Pronicka Poland 26 1.2k 1.8× 93 0.3× 326 1.8× 159 1.1× 88 0.7× 114 2.0k
Thomas M. Connor United Kingdom 14 517 0.8× 145 0.5× 81 0.4× 51 0.3× 51 0.4× 27 1.2k
A. Thomsen United States 17 1.1k 1.8× 128 0.5× 78 0.4× 122 0.8× 58 0.4× 32 1.5k
Michael E. Steffey United States 14 593 0.9× 323 1.2× 67 0.4× 78 0.5× 32 0.2× 18 1.0k
Ossama B. Kashlan United States 26 1.4k 2.2× 83 0.3× 88 0.5× 100 0.7× 62 0.5× 54 1.7k
Gen Wen United States 19 584 0.9× 56 0.2× 134 0.7× 84 0.6× 64 0.5× 34 1.3k
Icíar P. López Spain 20 331 0.5× 71 0.3× 78 0.4× 83 0.6× 45 0.3× 38 1.1k
J Blumer United States 27 1.2k 1.9× 50 0.2× 163 0.9× 74 0.5× 80 0.6× 58 1.7k

Countries citing papers authored by Yuko Watanabe

Since Specialization
Citations

This map shows the geographic impact of Yuko Watanabe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuko Watanabe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuko Watanabe more than expected).

Fields of papers citing papers by Yuko Watanabe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuko Watanabe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuko Watanabe. The network helps show where Yuko Watanabe may publish in the future.

Co-authorship network of co-authors of Yuko Watanabe

This figure shows the co-authorship network connecting the top 25 collaborators of Yuko Watanabe. A scholar is included among the top collaborators of Yuko Watanabe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuko Watanabe. Yuko Watanabe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ito, Yu, Jumpei Kondo, Shinya Matsuzaki, et al.. (2022). Ex vivo chemosensitivity assay using primary ovarian cancer organoids for predicting clinical response and screening effective drugs. Human Cell. 36(2). 752–761. 4 indexed citations
2.
Fujii, Shinya, Eriko Kikuchi, Yuko Watanabe, et al.. (2021). Structural Development of Salicylanilide‐Based SPAK Inhibitors as Candidate Antihypertensive Agents. ChemMedChem. 16(18). 2817–2822. 1 indexed citations
3.
Nakano, Tomohiro, S. Katayama, Tasuku Suzuki, et al.. (2021). Clofarabine monotherapy in two patients with refractory Langerhans cell histiocytosis. Cancer Reports. 5(8). e1579–e1579. 3 indexed citations
4.
Yamanishi, Kyosuke, Takuya Hashimoto, Wen Li, et al.. (2021). Exploring Molecular Mechanisms Involved in the Development of the Depression‐Like Phenotype in Interleukin‐18‐Deficient Mice. BioMed Research International. 2021(1). 9975865–9975865. 10 indexed citations
5.
Fujii, Shinya, Eriko Kikuchi, Yuko Watanabe, et al.. (2020). Structural development of N-(4-phenoxyphenyl)benzamide derivatives as novel SPAK inhibitors blocking WNK kinase signaling. Bioorganic & Medicinal Chemistry Letters. 30(17). 127408–127408. 7 indexed citations
6.
Yamanishi, Kyosuke, Nobutaka Doe, Takuya Hashimoto, et al.. (2019). Interleukin-18-deficient mice develop hippocampal abnormalities related to possible depressive-like behaviors. Neuroscience. 408. 147–160. 27 indexed citations
7.
Yamanishi, Kyosuke, Nobutaka Doe, Takuya Hashimoto, et al.. (2017). Molecular analysis of the mouse brain exposed to chronic mild stress: The influence of hepatocyte nuclear factor 4α on physiological homeostasis. Molecular Medicine Reports. 16(1). 301–309. 7 indexed citations
8.
Ishigami‐Yuasa, Mari, Yuko Watanabe, Takayasu Mori, et al.. (2017). Development of WNK signaling inhibitors as a new class of antihypertensive drugs. Bioorganic & Medicinal Chemistry. 25(14). 3845–3852. 12 indexed citations
9.
Yamanishi, Kyosuke, Seishi Maeda, Sachi Kuwahara‐Otani, et al.. (2016). Interleukin-18–deficient mice develop dyslipidemia resulting in nonalcoholic fatty liver disease and steatohepatitis. Translational research. 173. 101–114.e7. 39 indexed citations
10.
11.
Higuchi, Yusuke, Kenji Tokunaga, Yuko Watanabe, et al.. (2016). Lineage switch with t(6;11)(q27;q23) from T-cell lymphoblastic lymphoma to acute monoblastic leukemia at relapse. Cancer Genetics. 209(6). 267–271. 4 indexed citations
12.
Kimura, Tomonori, Tetsu Akimoto, Yuko Watanabe, et al.. (2015). Impact of Renal Transplantation and Nephrectomy on Urinary Soluble Klotho Protein. Transplantation Proceedings. 47(6). 1697–1699. 13 indexed citations
13.
Suefuji, Hiroaki, Hayato Kaida, Masanobu Hayakawa, et al.. (2013). Relationship between 2-deoxy-2-[18F]-fluoro-d-glucose uptake and clinicopathological factors in patients with diffuse large B-cell lymphoma. Leukemia & lymphoma. 55(3). 520–525. 13 indexed citations
14.
Akimoto, Tetsu, Kazuhiro Shiizaki, Yuko Watanabe, et al.. (2012). The relationship between the soluble Klotho protein and the residual renal function among peritoneal dialysis patients. Clinical and Experimental Nephrology. 16(3). 442–447. 31 indexed citations
15.
Watanabe, Yuko & Merrill Swain. (2008). Perception of Learner Proficiency: Its Impact on the Interaction Between an ESL Learner and Her Higher and Lower Proficiency Partners. Language Awareness. 17(2). 115–115. 8 indexed citations
16.
Suzuki, Yuichi, Satomi Tanaka, Yuko Watanabe, et al.. (2004). Mental state and sensory thresholds. 34(2). 64–69. 1 indexed citations
17.
Kuwahara, June, et al.. (2000). Zn finger and nuclear localization of transcription factor Sp 1. Nucleic Acids Symposium Series. 44(1). 265–266. 13 indexed citations
18.
Matsuzaka, Hiroyuki, Yuko Watanabe, Takashi Okubo, et al.. (2000). Preparation, Structure, and Reactivities of Amido-Bridged Dinuclear Rhodium(III) and Rhodium(II) Complexes. Organometallics. 19(3). 216–218. 17 indexed citations
19.
Muto, Shigeaki, et al.. (1996). Differential regulation of Na+-K+-ATPase gene expression by corticosteriods in vascular smooth muscle cells. American Journal of Physiology-Cell Physiology. 270(3). C731–C739. 26 indexed citations
20.
Kawakami, Kiyoshi, et al.. (1992). Identification and Characterization of the Cis-Elements Regulating the Rat AMOG (Adhesion Molecule on Glia)/Na,K-ATPase β2 Subunit Gene1. The Journal of Biochemistry. 111(4). 515–522. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guilai Liu Breakdown of academic impact, for papers by Tomohiko Okuda Breakdown of academic impact, for papers by Ewa Pronicka Breakdown of academic impact, for papers by Thomas M. Connor Breakdown of academic impact, for papers by A. Thomsen Breakdown of academic impact, for papers by Michael E. Steffey Breakdown of academic impact, for papers by Ossama B. Kashlan Breakdown of academic impact, for papers by Gen Wen Breakdown of academic impact, for papers by Icíar P. López Breakdown of academic impact, for papers by J Blumer
Rankless by CCL
2026